ArticleCell death discovery2026
Enhanced precision in cell culture analytics: leveraging artificial intelligence for unbiased and non-destructive assessment of cell growth and viability.
Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Precise assessment of cell growth, count, and viability is a prerequisite for biological and medical research. Traditional cell analytics involve manual processes, such as cell counting or reagent-based approaches that are user-dependent and prone to bias. Semi-automated systems for counting cells, tracking cell growth, and determining viability have been introduced over the past decades. However, these methods are often time-consuming, require labeling steps, and involve costly instrumentation and consumables. Changes in cell growth and/or viability create biological patterns that can be interpreted by artificial intelligence (AI). Here, we report the development and validation of SnapCyte™, an AI application that performs accurate, unbiased, label- and reagent-free cell analyses from basic cell culture images. Using cell lines with diverse morphologies in various culture conditions, we generated a comprehensive and fully annotated image database that was used for AI education. Convolutional neural networks were employed for cell localization and iterative training loops until a stable performance of >95% accuracy was obtained for all readouts. The fully trained AI demonstrated high Precision and Recall and performed with greater accuracy and less variation as compared to standard methods. As the SnapCyte analyses are performed on cell images only, data acquisition is non-invasive to the experimental setup, enabling real-time use of cells in downstream assays. In summary, SnapCyte is a fast and accurate cell analytics platform, resistant to user variations and independent of reagents or specific equipment, with improved performance over current cell analytics methodologies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.